Faculty

Dr. Nichols' research focuses on exploring the pharmacist’s role in substance use disorder (SUD) interventions and patient care. Her passion for this space is driven by her lived experiences growing up in a home where her mother struggled with alcohol use disorder.  To date, Dr. Nichols' scholarly efforts have specifically explored the following areas: (1) pharmacists’ knowledge and perceptions of opioids, opioid alternatives (e.g., cannabinoids), and medications for opioid use disorder; (2) pharmacists’ education and training on effective, evidence-based opioid interventions; and (3) efforts to advance community pharmacy practice. Dr. Nichols has received research support from the Agency for Healthcare Research and Quality and the American Pharmacists Association Foundation. 

PHRM 870 Health Policy Applications

PHRM 852 Public Health Pharmacy

PHPR 490 Advanced Community Pharmacy Concepts

American Association of Colleges of Pharmacy (AACP) Resident, Fellow, and Postdoc Trainee Best Poster Award (2022)

American College of Clinical Pharmacy (ACCP) Health Outcomes Practice and Research Network Travel Award (2021)

Indiana Pharmacy Teaching Certificate (IPTeC) Nicholas G. Popovich Excellence in Teaching Award (2020)

1. Nichols MA, Riley EG, Chao AS, Sales CG, Miller ML, Curran GM, Ott CA, Snyder ME, Hudmon KS. Opioid Use Disorder Content in US-Based Doctor of Pharmacy Programs. Am J Pharm Educ. (In press)
2. Nichols MA, Kepley K, Rosko K, Hudmon KS, Curran GM, Ott CA, Snyder ME, Miller ML. Community Pharmacist-Provided Opioid Intervention Frequencies and Barriers. J Am Pharm Assoc (2003). Jan/Feb 2023; 63(1): 336-342.
3. Comanici KH, Nichols MA, Scott C, Conklin M, Ott CA, Arnett SJ, Karwa R. Understanding the Role of Community Pharmacies in Current Medication for Opioid Use Disorder Care Practices. J Am Pharm Assoc (2003). Jan/Feb 2023; 63(1): 261-268.e2.
4. Mills AR, Nichols MA, Davenport ES. Chronic pain and medical cannabis: Review and practice considerations in persons living with HIV. J Am Coll Clin Pharm. Mar 2022; 5(3): 342-353.
5. Nichols MA, Arnett SJ, Fa B, Marchionda RA, Cutting MC, McDonald MR, Miller ML. National survey identifying community pharmacist preceptors’ experience, knowledge, attitudes, and behaviors influencing intent to recommend cannabidiol products. J Am Pharm Assoc (2003). Jul/Aug 2021; 61(4S): S91-S104.
6. Davenport ES, Arnett SJ, Nichols MA, Miller ML. Indiana community pharmacist preceptors’ knowledge and perceptions of medication-assisted treatment. J Am Pharm Assoc (2003). May/Jun 2020; 60(3S): S20-S28.e4.